1	Un	Un		C0205447_1	calificador_1	0-2	237_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
2	hombre	hombre	NCMS000	C0025266#C0086418#C0043210	persona#organismo_vivo	3-9	237_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
3	de	de	SPS00	C0332285	atributo	10-12	237_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
4	62	62		-	-	13-15	237_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
5	años	año	NCMP000	C0439234	calificador	16-20	237_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
6	con	con	SPS00	C0332287	atributo	21-24	237_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
7	una	una		C0205447_1	calificador_1	25-28	237_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
8	diabetes	diabetes	NCFN000	C0011860_1	trastorno_1	29-37	237_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
9	mellitus	mellitus	AQ0CN0	C0011860_2	trastorno_2	38-46	237_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-	8	97	MultiE
10	tipo	tipo	NCMS000	C0011860_3	trastorno_3	47-51	237_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	8	473	Modif
11	2	2	Z	C0011860_4	trastorno_4	52-53	237_QUEST_clinical_caseMIR	SENT1	I-Calificador	-	10	97	MultiE
12	de	de	SPS00	C0332285	atributo	54-56	237_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
13	10	10		-	-	57-59	237_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
14	años	año	NCMP000	C0439234	calificador	60-64	237_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
15	de	de	SPS00	C0332285	atributo	65-67	237_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
16	evolución	evolución	NCFS000	-	-	68-77	237_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
17	realiza	realizar	VMIP3S0	-	-	78-85	237_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
18	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	86-97	237_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
19	con	con	SPS00	C0332287	atributo	98-101	237_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
20	metformina	metformina	NC00SC0	C0025598	producto#sustancia	102-112	237_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-	-	-	-
21	y	y	CC	C1706368	calificador	113-114	237_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
22	sitagliptina	sitagliptina	NC00SC0	C1565750	sustancia#producto	115-127	237_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-	-	-	-
23	.	.	Fp	-	-	127-128	237_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-

1	Hace	hacer	VMIP3S0	-	-	129-133	237_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
2	ejercicio	ejercicio	NCMS000	C0015259_1	calificador_1	134-143	237_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
3	físico	físico	NCMS000	C0015259_2	calificador_2	144-150	237_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
4	escaso	escaso	AQ0MS0	C0443295#C0205169	calificador	151-157	237_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
5	y	y	CC	C1706368	calificador	158-159	237_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
6	realiza	realizar	VMIP3S0	-	-	160-167	237_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
7	una	una		C0205447_1	calificador_1	168-171	237_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
8	dieta	dieta	NCFS000	C0012155	hallazgo	172-177	237_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
9	adecuada	adecuar	VMP00SF	-	-	178-186	237_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
10	.	.	Fp	-	-	186-187	237_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	188-190	237_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
2	los	el	DA0MP0	-	-	191-194	237_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
3	últimos	último	AO0MP0	-	-	195-202	237_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
4	6	6		-	-	203-204	237_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
5	meses	mes	NCMP000	C0439231	calificador	205-210	237_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
6	ha	haber	VAIP3S0	-	-	211-213	237_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
7	perdido	perder	VMP00SM	-	-	214-221	237_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
8	peso	peso	NCMS000	C0043100	calificador	222-226	237_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
9	y	y	CC	C1706368	calificador	227-228	237_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
10	tiene	tener	VMIP3S0	-	-	229-234	237_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
11	más	más	RG	C0205172	calificador	235-238	237_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
12	astenia	astenia	NCFS000	C0004093#C3714552	hallazgo	239-246	237_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-	-	-	-
13	.	.	Fp	-	-	246-247	237_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-

1	Sus	su	DP3CP0	-	-	248-251	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
2	controles	control	NCMP000	C2587213	atributo	252-261	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
3	glucémicos	glucémico	AQ0MP0	-	-	262-272	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
4	se	se	P00CN000	-	-	273-275	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
5	han	haber	VAIP3P0	-	-	276-279	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
6	deteriorado	deteriorar	VMP00SM	-	-	280-291	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
7	pasando	pasar	VMG0000	-	-	292-299	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
8	de	de	SPS00	C0332285	atributo	300-302	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
9	glucemias	glucemia	NCFP000	C2585282	entidad_observable	303-312	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
10	basales	basal	AQ0CP0	C0205112	calificador	313-320	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
11	de	de	SPS00	C0332285	atributo	321-323	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
12	110-140	110-140	Z	-	-	324-331	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
13	mg	mg	NCMN000	-	-	332-334	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
14	/	/	Fh	-	-	334-335	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
15	dl	decilitro	NCMN000	C0439241	calificador	335-337	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
16	a	a	SPS00	-	-	338-339	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
17	glucemias	glucemia	NCFP000	C2585282	entidad_observable	340-349	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
18	de	de	SPS00	C0332285	atributo	350-352	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
19	170-200	170-200	Z	-	-	353-360	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
20	mg	mg	NCMN000	-	-	361-363	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
21	/	/	Fh	-	-	363-364	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
22	dl	decilitro	NCMN000	C0439241	calificador	364-366	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
23	,	,	Fc	-	-	366-367	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
24	así	así	RG	-	-	368-371	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
25	como	como	SPS00	C0332257	calificador	372-376	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
26	su	su	DP3CS0	-	-	377-379	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
27	hemoglobina	hemoglobina	NCFS000	C0019046	sustancia	380-391	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
28	glicosilada	glicosilada	VMP00SF	-	-	392-403	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
29	que	que	PR0CN000	-	-	404-407	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
30	ha	haber	VAIP3S0	-	-	408-410	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
31	pasado	pasar	VMP00SM	-	-	411-417	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
32	de	de	SPS00	C0332285	atributo	418-420	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
33	7,1	7,1		-	-	421-424	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
34	a	a	SPS00	-	-	425-426	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
35	8,5	8.5	Z	-	-	427-430	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
36	%	%	Ft	-	-	430-431	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
37	.	.	Fp	-	-	431-432	237_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-

1	La	el	DA0FS0	-	-	433-435	237_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
2	medida	medida	NCFS000	C0079809	atributo	436-442	237_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
3	terapéutica	terapéutico	AQ0FS0	-	-	443-454	237_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
4	más	más	RG	C0205172	calificador	455-458	237_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
5	adecuada	adecuar	VMP00SF	-	-	459-467	237_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
6	a	a	SPS00	-	-	468-469	237_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
7	realizar	realizar	VMN0000	-	-	470-478	237_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
8	es	ser	VSIP3S0	-	-	479-481	237_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
9	:	:	Fd	-	-	481-482	237_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
10	.	.	Fp	-	-	482-483	237_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-

